DocDollars

Swedish Orphan Biovitrum Ab

Sweden · Reporting entity ID 100000081405

Total reported 2019–2025
$31.9M
#226 of 2,960 reporting companies — 0% of all reported industry payments
$1.13M in general payments across 296 records, plus $30.8M in research funding across 1,922 records.

How it breaks down

General payments $1,131,567
Research funding $30,768,462

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Swedish Orphan Biovitrum Ab reported $31.9M to US doctors and teaching hospitals from 2019 to 2025, ranking #226 of 2,960 reporting companies. 96% of that was research funding and 4% general payments such as consulting, speaking, food and travel. 296 general payment records and 1,922 research records were filed.

Common questions about Swedish Orphan Biovitrum Ab

How much has Swedish Orphan Biovitrum Ab paid US doctors?

Swedish Orphan Biovitrum Ab reported $31,900,028 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $1,131,567 in general payments, $30,768,462 in research funding.

How does Swedish Orphan Biovitrum Ab rank among drug and device companies?

It ranks #226 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Swedish Orphan Biovitrum Ab mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.